10/11/2022 BioPharma Dive: Brain disease startup Neumora draws more funding for ambitious research plan Read More
10/11/2022 Boston Business Journal: Amgen-partnered neuroscience startup rakes in another $112M Read More
09/23/2022 Endpoints: The Endpoints 11: The top private biotechs in pursuit of new drugs. Pushing the envelope with powerful new technologies Read More
10/07/2021 STAT: Backed with $500 million, a startup aims to rethink psychiatric drug development Read More
10/07/2021 Endpoints: ARCH unveils its Really Big Neuroscience Company with $500M, an Amgen deal and eyes on depression, Alzheimer’s and a lot more Read More
10/07/2021 Business Insider: A new startup created by one of biotech’s biggest VCs shows you need to go big to treat brain disorders Read More
10/07/2021 Biopharma Dive: Armed with half a billion dollars, a startup aims to change how brain drugs are made Read More
10/07/2021 Timmerman Report: Neumora Secures $500M, Amgen Deal, in Quest for Neuroscience R&D Read More